Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation (Details 3)

v3.22.1
Share-Based Compensation (Details 3) - Anti-dilutive Deferred Stock Units [Member]
3 Months Ended
Mar. 31, 2022
$ / shares
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Number of shares, Beginning balance | shares 2,052,474
Number of shares, Granted | shares 0
Number of shares, Vested | shares (958,850)
Number of shares, Forfeited | shares (20,551)
Number of shares, Ending balance | shares 1,073,073
Weighted-average grant-date fair value per share at beginning of period | $ / shares $ 1.49
Weighted-average grant-date fair value per share, Granted | $ / shares 0
Weighted-average grant-date fair value per share, Vested | $ / shares 1.40
Weighted-average grant-date fair value per share, Forfeited | $ / shares 1.16
Weighted-average grant-date fair value per share at end of period | $ / shares $ 1.59